Prosecution Insights
Prosecution Insights
9 pending office actions • 9 art units • 9 examiners • 0 of 9 (0%) have an AI response strategy ready • 16 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 9 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 9 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (22%) |
| §112 only | 4 (44%) |
| No statute on record | 3 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SONG, JIANFENG | 1 | 56.1% | +33.5% |
| ZHU, QIN | 1 | 87.7% | +2.6% |
| ROMERO, KRISTEN WANG | 1 | 71.4% | +29.6% |
| CORDAS, EMILY ANN | 1 | 50.6% | +58.5% |
| NOTTINGHAM, KYLE GREGORY | 1 | 60.8% | +33.8% |
| WANG, CHANG YU | 1 | 33.6% | +53.0% |
| OH, TAYLOR V | 1 | 81.1% | +15.4% |
| STEELE, AMBER D | 1 | 59.1% | +9.1% |
| STOCKTON, LAURA LYNNE | 1 | 75.0% | +33.8% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17771241 | NOVEL SUBSTITUTED CONDENSED RING COMPOUND | OH, TAYLOR V | 118d overdue |
| 18545081 | DISPLAY CONTROL APPARATUS, AND DISPLAY CONTROL METHOD | ZHU, QIN | 110d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18113887 | THERAPEUTIC DRUG FOR MOTOR COMPLICATIONS IN PARKINSON'S DISEASE | NOTTINGHAM, KYLE GREGORY | 119d overdue |
| 17771241 | NOVEL SUBSTITUTED CONDENSED RING COMPOUND | OH, TAYLOR V | 118d overdue |
| 18258989 | THERAPY BASED ON SYNTHETIC LETHALITY IN SWI/SNF COMPLEX-DYSFUNCTION CANCER | ROMERO, KRISTEN WANG | 87d overdue |
| 13895089 | NOVEL BICYCLIC HETEROCYCLIC COMPOUND | STOCKTON, LAURA LYNNE | 42d overdue |
| 17794912 | DETERMINATION AGENT AND DETERMINATION METHOD FOR TAUOPATHY AND DEMENTIA-RELATED DISEASES | WANG, CHANG YU | 26d overdue |
| 18723166 | 1H-PYRAZOLE-3-AMINE DERIVATIVE HAVING BICYCLIC BACKBONE | SONG, JIANFENG | 15d overdue |
| 18025036 | Complex Containing Neural Retina-Containing Cell Aggregates and Matrix, and Method for Manufacturing Same | CORDAS, EMILY ANN | 7d |
| Art Unit | Apps |
|---|---|
| 1613 | 1 |
| 2691 | 1 |
| 1624 | 1 |
| 1632 | 1 |
| 1621 | 1 |
| 1675 | 1 |
| 1625 | 1 |
| 1658 | 1 |
| 1626 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18723166 | 1H-PYRAZOLE-3-AMINE DERIVATIVE HAVING BICYCLIC BACKBONE | SONG, JIANFENG | 1613 | §112 | Non-Final OA | 15d overdue | Pending | Jun 21, 2024 |
| 18545081 | DISPLAY CONTROL APPARATUS, AND DISPLAY CONTROL METHOD | ZHU, QIN | 2691 | §103 | Non-Final OA | 110d overdue | Pending | Dec 19, 2023 |
| 18258989 | THERAPY BASED ON SYNTHETIC LETHALITY IN SWI/SNF COMPLEX-DYSFUNCTION CANCER | ROMERO, KRISTEN WANG | 1624 | Other | Non-Final OA | 87d overdue | Pending | Jun 22, 2023 |
| 18025036 | Complex Containing Neural Retina-Containing Cell Aggregates and Matrix, and Method for Manufacturing Same | CORDAS, EMILY ANN | 1632 | §112 | Non-Final OA | 7d | Pending | Mar 07, 2023 |
| 18113887 | THERAPEUTIC DRUG FOR MOTOR COMPLICATIONS IN PARKINSON'S DISEASE | NOTTINGHAM, KYLE GREGORY | 1621 | Other | Non-Final OA | 119d overdue | Pending | Feb 24, 2023 |
| 17794912 | DETERMINATION AGENT AND DETERMINATION METHOD FOR TAUOPATHY AND DEMENTIA-RELATED DISEASES | WANG, CHANG YU | 1675 | §112 | Non-Final OA | 26d overdue | Pending | Jul 22, 2022 |
| 17771241 | NOVEL SUBSTITUTED CONDENSED RING COMPOUND | OH, TAYLOR V | 1625 | §112 | Non-Final OA | 118d overdue | Pending | Apr 22, 2022 |
| 17279807 | INJECTABLE COMPOSITION | STEELE, AMBER D | 1658 | Other | Non-Final OA | 111d overdue | Pending | Mar 25, 2021 |
| 13895089 | NOVEL BICYCLIC HETEROCYCLIC COMPOUND | STOCKTON, LAURA LYNNE | 1626 | §103 | Final Rejection | 42d overdue | Pending | May 15, 2013 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial